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PRI!PACE

FOREWORD
The Blreau of Radiological Health develops and carries out a national program to
control unnecessary human expo_e to potentially hazardous ionizing and nonionizing
radiations and to ensu-e the safe, efficacious use of such radiations. The Blreau publishes
the results of its work in scientific joIrnals and In Its own technical reports.
These reports provide a mechanism for diueminating results of Blreau and contrac.1or
projects. They are distributed to Federal, State, and local governments; industry; hospitals;
the medical profession; educators; researchers; libraries; professional and trade organizations; the presS; and others. The reports are sold by the Government Printing Office and/or
the National Technical Information Service.
The Blreau also makes its technical reports available to the World Health Organization.
Under • memorandum of aweMlent betw..en WHO and the Department of Health and
H.man Services, three WHO Collaborating Centers have been established within the Blreau
of Radiological Health, FDA:

The Division of Biological Effects of the 8<reau of Radiological Health plans, conducts,
and SI4lP«ts experimental and epidemiological research on the biological effects of
exposlle to Ionizing and nonionizing radiation.

An important area of research that has received recent attention by both the division
and groups outside BRH is the delayed effects of exposure to low levels of Ionizing
radiation. In the 1960's a study of school children In three southwestern states was
conducted by the Blreau of Radiological Health to exantine a possible association between
exposure to fallout from nuclear weapons testing and thyroid tumor development. No such
association was found, but the post-exposure follo ...... period was short, and the study group
was small. The goal of the present study is to determine the feasibility of locating and
resllveylng the previously studied group of persens exposed to radioactive fallout. The
results are expected to be important in deciding whether or not to pursue a fuJI-scale
investigation of the original or expanded study group In view of continued concern about the
possible health effects of exposure to low levels of fallout radiation.

WHO Collaborating Center for Standardizati.,n of Protection Against Nonionizing
Radiations;

WHO Collaborating Center for Training and General Tasks in R3diation Medicine; and
WHO Collaborating Center for Nuclear Medicine.
Please report errors or omissions to the Blreau.
further information are also enCOllaged.
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Moris L. Shore, Ph.D.
Director
Division of Biological Effects
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?,mplete;d for most chlleren in order to elicit relevant medical and demographic
Information. Laboratory tests were performed on sera from all children referred to the
panel and from a sample of chlleren considered to have normal thyroid glands. estimates of
thyroid gland dose from Ilil exposI6e were made.

A Pl!ASIBlUTY STUDY OF THE BIOLOGICAL I!PPECTS OF FALLOUT

ON PI!OPLE IN UTAH, NEVADA, AND ARIZONA

ThIs Is the final report of the analysis of the Utah, ~vada, and Arizona Thyroid
FeaslbWty Study. The report Is divided Into four sections. (J) Introduction and 8ackgn'ood;
(2) AnalysIs of Unlca&e stuct· with the Utah Cancer Rqlstry and Rock"1 Mountain Cancer
Data System; (3) Evaluation of Traclns a Sample of the Original Utah, Nevada, and Arizona
Study Groups; and (4) OptIons for FIrtlft Studies.

INTROOUCTJON AND BAClCGROUND
For a time the thyroid gJand was thousht to be relatively radioremtant. However, In
the last three decades several studies have demonstrated a strong association between
external irradiation and the late development of thyroid neoplasia, both malignant and
ben~(1~).

The dat.a did not demonstrate an Increase in the Incidence of thyroid neoplasia In the
exposed children. However, the sample size of the exposed group was too small to detect
anything less than an 18-fold increased risk of thyroid cancer with sufficient statistical
probability. In addition, the mean time since expos," was 14 years. Since the minimal
latency period for radiation-induced thyroid cancer Is at least 1.5 years and perhaps greater
(9), and thyroid cancer associated with previous Irradiation appears as I~g as 30 years after
expos," CIO), the chUeren in the original study may not have been followed long enough for
the Slow-growing .thyroid tumors to become manifest if present. Therefore, a second
follow..., of the original study population, with an additional 12 years of risk, would more
!'dequately. te.s t the hypothes!, of whether fallout exposI6e to nil is associated with an
Increased Incidence of thyroid cancer or of total cancer In former school chIJeren from
southwestem Utah and Nevada.

The U~h Thyroid Feasibility Study was conducted in direct response to both Iqislatlve
and executive concem over possible delayed health effects from nuclear weapons testing at
the Ne~ada test site in the I"O's. The study was Initiated in March, I 979, and was completed In August, I 980. The feasibility study was conducted to determine if a second
followup .o~ .the original Utah, Nevada, and Arizona study groups was possible. Specifically,
the feaSibility study consisted of two separate tasks: (J) to assess available cancer
mortality and morbidity data by linking the original study records with a tumor registry in
Utah; and (2) to locate a stratified sample of the original study gro...,s.

Other studies have suggested an association bet_ Internally delivered radiation to the
thyroid gJand from radioactive Iodine, primarily 131" and the appearance of thyroid gland
neoplasia In animals and man (~). Many of these studies, both of external Irradiation and
Intem~ Ill, expos'", suggest that the rapidly proJlferatins thyroid gJand in infants and
chlldre Is h1s/1ly sensitive to the effects of Ionizing radiation (9).

Ourlng the last half of the 19~'s and 1960's, concem developed over population
exposlftS to short-lived radioisotopes and In particular Ilil as a consequence of fall out
from .-..clear weapons test1ns at the Nevada test site. As the biological pathway of 131 1 was
ascertained and estimates were made of the potential dose to the thyroid glands of young
children consuming milk with dete::table levels of Ill, activity, the possibility was recognized that per*>nS residing in h1Rh fallout areas in Utah and ~vada m1s/1t have been
exposed to tumorigenic doses of I11L

In response to this concem, the Blftau of Radiological Het.lth (then the National Center
for Radiological Health), in 1964, initiated a aoss-sectJonal study of chlleren In Utah,
Nevada, and Arizona to determine whether expos'" to fallout from nuclear weapons testing
In Nevada was associated with an Increased risk of thyroid neoplasia. Children I I through
IS years of age, attendins school grades 6 throus/l 12 In Washlnston County, Utah, Lincoln
Cowlty, Nevada, and Graham Cowlty, Arizona, were eligible for Inclusion In the study. The
exposed study sroup (N=I,37S) consisted of chlleren residing In Washington County, Utah,
and Uncoln County, Nevada, prior to January I, 1960. Two comparison groups were
Include.h (I) chlJeren (NsI,3Il) who moved Into these two counties after December 31, 19"
and, therefore, received minimal expos'" to fallout; and (2) chlleren (N=2, I 40) In Graham
Cowlty, Arizona, where no detectable levels of fallout were recorded.
Physicians, with special training in thyroid gland palpation, examined these chlleren
annually from 196' through 196& for evidence of thyroid disease. Special attention was
given to gland usymetry, enlargement, and nodularlty. The physicians were divided Into
two teams, and three physicians Independently examined the thyroid gland of each child.
Children reported to have a thyroid abnormality were referred to a panel of three
experienced thyroldologJsts for f ... ther evaluation. In addition, questionnaires were
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EVALUATION OF THE UTAH CANCER REGISTRY (UCR) AND ROCKY MOUNTAIN
CANCER DATA SYSTEM (RMCDS) RECORD LINKAGE
A copy of a computer tape containing the names of individuals in the initial BRH study
along with other relevant information was sent to UCR!RMCDS in Noven:ber, 1979. ThIs
tape (PHS file) was created during the summer of 1979 by coding and keyp~hIng information from the original study questionnaires.
The PHS file was matched to the UCR!RMCDS flIes to search for persons In the original
study who may have developed and reported a cancer between 1966 and 1978. The fUes
were matched by sex, and month and year of birth. Both last name and first name lists were
created within these age and sex categories. The lists were then compared for matches.
When possible matches were identified, the abstracts on file in the registry for these cues
were examined for detailed information to verify a match. Information used for verWcation included: parents' names, malden names, residence at time of diagnosis, place of birth,
birth date, and any other Information avallable. When a match could not be determined
with data located at the registry, the treating hospital and/or physician was contacted. For
deceased persons, death certificates were obtained and reviewed for information which
could verify a match between name (maiden name for females), parents' na~, and approximate date of birth. The procedure was similar for linkage to RMCDS except that the data
coded in this registry was not as complete as that in the UCR.

After searching the UCR/RMCDS files, 62 possible matches were identified and ., cases
were verified ~ true matches·· 12 in Utah, 1 in Nevada, and 2 in Arizona (Table 1). Before
the names of these individuals could be released to BRH, authorization was obtained.
Coverage of the UCR!RMCDS registries is 98 percent complete for Utah while for
Nevada and Arizona, neither of which has a population-based tumor registry, it is far less
complete. Therefore, the findings in Utah cannot be directly compared with those in
Nevada and Arizona because of this discrepancy in completeness of ascertainment. Consequently, only those cancers identified in the Utah study group wlll be discussed.
Of the 12 cases found in the Utah group, 9 were classified as exposed and 3 were

W1eX-

posed based on the original study criteria (residence in Washington County, Utah, before
January 1, 1960, characterized the exposed group; persons who moved into the area on or

after January 1, 1960, were the ~xposed group). Two of the 12 cases, 1 hydatidiform
mole in each group, were excluded because they were not recognized as true neoplasms
lI'lless they developed into choriocarcinoma.

Expected numbers of cancers were calculated for the exposed and unexposed groups in
the foliowing mariner: (1) person-years were calculated, using the cohort approach, over
calendar time and within .s-year age groups; (2) the perso -years by .s-year age groups were
summed "ver calendar time from January 1, 1"3, through December 1, 1978, (3) cancer
incidence rates specific for race, sex, and age from the 3rd Ncttional Cancer S\rVey (TNCS)
were multiplied by the age-and sex-specific person-years and summed over all age and sex
groups for cancer of all sites an(j of specific sites (11).
The expected numbers of cancers calculated In this ma..,r,er are subject to several
assumptions which would probably make these numbers larger than "true" expectation.
First, in estimating the person-years over cak'ldar time and within .s-year age groups, it
was assumed that no deaths or loss-to-follow\1j> ,K:curred in both the exposed and W1exposed
groups. This inflates the number of person Ye3rs and leads to an overestimate of the
expected numbers. Second, the rates from the TNCS specific for site, age, race, and sex
were used to estimate the numbers of cancers in both groups. The use of these rates could
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Table 1.

Sex

Exposure
status

Month.year of
dialnos1e

Age at
diaeos1e

1
2*
3
4*

K
K
K

F

Exposed
Unexposed
Exposed
Exposed

01/73
08/73
02/72
J5/71

19
22
18
19

5+

K

Unexposed

04/68

16

6

K

Unexposed

06/76

25

7*
8
9
10

'"

F
F
F

Exposed
Exposed
Exposed
Exposed

08/75
11/76
12/78
12/67

27
23
29
19

11
12
13

F
F
F

Exposed
Unexposed
Unexposed

04/79
03/70
01/77

28
20
23

14
15

F
F

Exposed
Unexposed

1970
02/70

22
19

Case nuaber

*

Su..ary of data of cancer cases of persons in original thyroid study
found in Utah Cancer Registry and Rocky Mountain Cancer Data System

deceased

+ identified in first study

Histology and
site of tU80r
Hodgkins' ly.phoaa
Testicular seainoaa
Testicular teratoaa
Acute .,eloblastic
leukell1a
Adenocarcinoaa of
thyroid gland
Infiltrating ductal
Ca of rt. breast
Multiple .,eloaa
Ca of parotid gland
Bydatidifora .ole
Sqaa.ous cell Ca
of cervix uteri
Ca of breast
Hydatidifora .ole
Acute .,eloblastic
leukell1a
Hodgkins' ly.pbo..
Argentaffine Ca
of appendix

lead to an overestimation of the expected numbers because the TNCS rates are O'osssectional covering 3 years (1969-1971) and, therefore, do not reflect temporal changes in
site specific rates. Furthermore, the cancer incidence rates in Utah tend to be lower than
Uf'ited States rates for all sites and for specific sites. However, according to Dr. lyon of
the University of Utah, the Utah cancer rates for persons less than 30 years of age (as in the
study groups) are compatible with the TNCS rates.
Table 2 presents the results of these calculations. The observed number of cancers
divided by the number of expected cancers results in an observedlexpected ratio (OlE)
which is a measure of association between a risk factor and disease. An OlE ratio of 1 indicates there is no difference between the number of cancers observed and the number
expected. Ninety-five percent confidence limits for the OlE ratio were calculated using an
exact method which assumes the observed number has an underlying Poisson distribution
(12).

In the exposed group, there was a total of 8 cancers observed and 7.7 expected
(OlE = 1.04) which is not significantly different from 1. In the unexposed group, 2 cancers
were observed and 7.' expected (OlE = 0.27) which is significantly less than 1 (p S .0 O.
For cancers of specific sites, in the exposed group there was 1 cancer of the breast, 1 each
for the male and female genital organs and the buccal cavity, 1 leukemia, 1 multiple myeloma, and 2 cases of Hodgkins' lymphoma. The only statistically significant difference
occuired for multiple myeloma where 1 case was observed and 0.001 expected (O/E=1000,
p < .001). There was no difference between the observed and expected numbers for the
combined group of leukemia or cancer of the thyroid gland and female breast, all of which
have bP.en associated with radiation exposure. In the unexposed group, there was 1 digestive
cancer and 1 leukemia.
The one case of multiple myeloma in the exposed group is interesting for two reasons:
(1) multiple myeloma is a very rare cancer in persons under 3' years of age. In the UNCS,
only 2 cases were observed in white males and females over a 3-year period (1969-197 1) in 9
population-based tumor registries that represented a population of over 10,000,000 persons
under the age of 3', and (2) an increased risk of multiple myeloma has been reported in
populations exposed to ionizing radiation. These include persons exposed to the atomic
bombs in Hiroshima and Nagasaki (13), workers at the Hanford nuclear reactor (14), and
radiologists (U). An interesting feature of the case observed in Utah was that the person
developed multiple myeloma 22 years after exposure, which is in agreement with the
Japanese data where the risk for myeloma in the high exposure group became apparent
about 20 years after exposure (13). However, the observation of 1 case in the exposed Utah
group should be interpreted with caution because it is only I case. It could be a random
event and not related to fallout.

In conclusion, the results from UCR/RMCDS record linkage study are subject to several
caveats, as discussed previously and should be interpreted with these caveats in mind. The
number of observed cancers is, in all likelihood an underestimate of the true number of
cancers in both the exposed and unexposed groups because (1) persons who emigrated from
Utah and developed cancer elsewhere would not be reported to the UCR/RMCDS registries,
and (2) malignancies which may have occurred between 19'3 and 196' in persons who otherwise would have been in the study were probably not identified. Furthermore, differential
migration probably occurred in that the unexposed group had aU moved into Washington
County after 19'9 and more of these people may have subsequently left the area. therefore, the number of cancers observed in the linkage study represents a minimal estimate of
the "true" number of cancers in the study groups, with the unexposed group probably
experiencing a greater degree of underascertainment than the exposed group. This aspect
will be discussed in the evaluation of the tracing study.
While the results of the matching study are open to different interpretations, it is
readily apparent that the UCR/RMCDS tumor registries were successfully utilized to match
their data files with the PHS file in identifying cases of cancer in the original Utah study
groups.
5

Table 2.

Site

Observed (0) and expected (E) numbers of cancers by site with OlE ratios
and 95 percent confidence limits (CL) for OlE ratios, Utah study
population only.

Utah exposed

(1)

All sites
Buccal cavity
& pharynx
Digestive
Respiratory
Bone
Soft tissue
Melano. .
Breast
lema Ie genital
Male genital
Urinary
Brain & CNS
Thyroid
Hodgkins'
lyllpho. .
Multiple
.yeloma
Leulteaia

0

E

OlE

8

7.7

1
0
0
0
0
0
1
1
0
0
0

0.2
0.4
0.2
0.3
0.3
0.4
0.3
0.9
0.5
0.3
0.7
0.7

2
1
1

1

Utah unexposed
95% CL
lower upper

0

E

1.04

0.45

2.05

2

7.5

5.00

0.06

27.8

3.33
1.11
2.00

0.04
0.02
0.03

18.5
6.18
11.1

0
1
0
0
0
0
0
0
0
0
0
0

0.2
0.4
0.2
0.3
0.3
0.4
0.3
0.5
0.5
0.3
0.8
0.6

1.3

1.S4

0.17

5.56

0

1.2

.001
1.0

1000
1.00

13.1
0.01

5563.0
5.56

0
1

.001
1.1

OlE

95% CL
lower upper

0.27

0.03

0.96

2.50

0.03

13.9

0.91

0.01

5.06

Observed cancers identified in Utah Cancer Registry
Expected nuabers based on sex and race-specific incidence rates by 5-year age
groups fro. Third National Cancer Survey.
(1) Excludes

two

hydatidifora moles, one in each group

Utah exposed - 1,273 persons

Utah unexposed - 1.031 persons

EVAL'JATlON l !' TRACING A SAMPLE OF THE ORIGINAL
UTAH, NEVADA, AND ARIZONA STUDY GROUPS
ThIs part of the feasibility study was conducted for the following reasons:
(I)

to assess the 'easlbility of locating a large proportion of the original study groups
and to evaluate migration patterns In the exposed and ooexposed grOUPSI and

(2) to evaluate the strengths and difficulties Inherent In particular location methods
and to estimate location costs In a followup of the entire study group.
The tracl", was conducted by Equlfax Systems Inc. A random sample of 301 persons
(about 6 percent of the entire original study group) ..... selected for tracl",. The sample
..... stratWed on sex and State of residence 10 that there were 6 strata, each containing ~
1ndIviclaIs (one stratum of Utah females had
BRH drew the sample and provided IdentIfier information for each person to be located. ThIs data Included name, sex, birth date,
marital statUi as of I 'J6I, religion, parents' names and Social Security number .. names of
sibil",.. and last known address. The goa1 was to locate and determine vital statUi for at
least 90 percent of the Individuals In each stratum.

,1).

Of the 301 persons In the sample, the vital statUi of 97 percent or 292 persons In the
study groups was definitely established. Of the 292 perlOl1l traced, 216 were fOl.lld to be
alive and 6 deceued. Death certWcates were obtained for the 6 deceased persons. Table 3
presents the location statUi for each of the ~ ~rata. There were no differences between the
strata In the rate of location. Consequently, in light of the high rate of success In locating
the sample, it appears that tracing of the ....tlre study group Is feasible.
Tabl. 3.

Location .tatua by ••x and State of original re.ld.nce

Lo cat i on .t.tu.
Sex aad State of
ort,inal re.ld.nce

Pound

%

Hot located
%
I

I

Total

%

Utah . . 1••
Utah f . . . l ..

48

SO

96.0
98.0

4.0
2.0

51

SO

100
100

Sa.ad. ul ••
laved. f ... l ••

49
47

98.0
94.0

2.0
6.0

SO
SO

100
100

Art.ou .. 1••

49
49

98.0
98.0

2.0
2.0

SO
SO

100
100

Total . . 1. .
toul f ...le.

146
146

97.3
96.7

4
5

2.7
3.3

ISO
lSI

100
100

tou l

292

97.0

9

3.0

301

100

Arizona l ... l ••

Table 4 presents the distribution, by State and sex, of the final IOUrce of Information
which determined the location and vital status of each person. A significantly greater number of males than females were located t ....ough mailed letters (3996 versus 2396, P < .0').
Conversely, a significantly greater number of females than males were located through field
investigations (.5496 versus 3996, P < .0.5). The difference between males and females in
location sources can be partially attributed to the fact that S6 percent of the women In the
study groups were married since the original study, thereby changing their name. ThIs
would result in greater difficulty in locating these persons.
Field investigations were the most frequent source utilized to locate persons In the study
sample, accounting for 46 percent of those located. It was aIIO the most expensive resource
with an average cost per located person of $91. The next most frequently used location
resource was the mailed letters. ThIs accounted for 31 percent of located persons with an
average cost of $17 per located person. The overall cost per located person was $6'.
The exposlft status of the persons In the sample was determined after the list of names

was received from Equlfax. The definition of exposlft status has been described previously.

The distribution of persons In the sample by exposlft status and residence at followup Is
presented in Table'. Before describing the results of this analysis, definitions of followup
residence status ~ presented In Table' arel

(J) StiU in same county - this refers to the county of residence In the original study.

For example, a person residing In Washington County, Utah, in the original rtudy,
arod stiU living In this county on the most recent foUowup, was classified as "stUi
In the same countY";

(2)

Stili in same State - this refers to the State of residence In the orlRlnaI study.
For example, a person residing In Washington CO\.Ilty, Utah, In the orIginal study,
but having moved t o some other location in Utah outside of Washington County by
the most recent followup, was classified as "still In the same State"1

()

Stili in 3-State area - refers to the State of residence In the original study. For
example, a person residing in Lincoln County, Nevada, In the orl.pnal study, but
found to be Uving In either Utah or Arizona on the most recent followup, was
classified as "stiU In the 3-State area" (that Is in either Utah, Arizona, or
Nevada);

(4) Left the 3-State area - the person was no longer in the 3-State area; and
(,) Not located - the current residence could not be determined.
Table .5 demonstrates differences between exposlft categories In the residence status.
For example, If the analysis is confined to the Utah and Nevada residents, a significantly
greater number of exposed perlOnS were stl11l1vlng In the State In which they resided in the
original study (70 versus ' 096, p < .0.5) whUe, conversely, a significantly greater number of
l.Ilexposed persons had left their original State of residence (3996 versus 2S'iIII, p < .0.5).
ThIs confirms the Initial impression that differential migration occurred between the
exposed and l.Ilexposed groups and that the l.Ilexposed group was more transient. A greater
percentage of lI'Iexposed than exposed persons in Utah and Nevada could not be located (S'iIII
versus O'illl). ThIs also reflects the greater moblllty of the l.Ilexposed group. It appears that
the ooexposed Arizona group ,1s similar to the Utah-Nevada exposed groups In regard to residence stability. Seventy-one percent of this group stili resided in Arizona :x>mpared with 70
percent for the Utah-Nevada exposed groups.
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tabla 4.

The flncltnss from the traclll8 pert of the feaslbl11ty study can be related to the results
of the Un....e study with the UCR/RMC05. Since coverage for Utah by the UCR Is 91 percent complete, only the Utah group wlJ1 be considered. In the conclusions to the Unlcase
study, It was stated that the numbers of cancers observed represented a minimal estimate
of the "true" numbers of cases as a consequence of underascertalnment due to emlsratlon of
the study groups. It was also felt that the uneXJlC*!d group experienced a sreater de&ree of
underascertalnment because they were a more transient population. As seen In Table " 7'
percent of the Utah eXJlC*!d group still resided In the State of Utah, and any cases of cancer
appearlns In this group should be reported to the UCR. Therefore, If the results from the
foUowup of the sample are appUed to the entire study group, the de&ree of underascerta1nrnent In the exposed group Is approximately 2' percent. ThIs comperes with an estimated
underascertalnment rate of 40 percent In the unexposed Utah group where only 60 percent
of the study group sample were stlU Uvtns In Utah. In reality, the level of underascertalnment may not be as sreat as this since 1 percent of the exposed and 20 percent of the
unexposed groups moved either to Nevada or Arizona. Partial Coverase Is provided by the
RMCOS res1stry In these two states, prlmarUy for Las Vqas, Tuscon, and PIloenIx.
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Successful tracing of a sample of the original study sroups and Iinkase of the study
records with the UCR/RMCDS Indicate that a fuU-scale foUowup of the entire Utah,
Nevada, and Arizona study groups is feasible.
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In conclusion, It Is evident from the h1Sh level of success In the traclll8 study that It Is
feasible to locate at least 90 percent of the unexposed and exposed members of the study
groups.
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Because of limitations in .,xistill8 exposure information, definitiv., epidemiologic
studies of these populations cannot be done. Despite these limitations, howev.,r, useful and
important studies may be possible to determine whether ther., are detectable health problems in expoo..d Individuals associated with radioactlv., fallout a quarter century after .,xposure. U health problems are observed, improved dosim.,try w1l1 be necessary to investigate
the issue and nature of dose-r.,sponse relationships. The ensuins discussion presents the
various strengths and weaknesses of three options conc.,ming continuation of the study.
Option AI

Conduct a full-scale foUowup of the or1&1nal study groups

One approach would be to keep the present study design and perform a second
quest lonnalr., survey of the original study groups, acceptill8 the fact that due to the small
size of the expoo..d group a thyroid cancer risk less than I-fold would probably not be
detected (a risk this hl&h or sreater is unlikely). The decision to conduct the study with this
serious shortcomins would, in all probability, be made on the basis of factors other than
scientific merit. One advantas., to this approach is that the study population has already
been assembled. The results .,f the feasibility study clearly Indicate that these persons can
be successfuUy traced. A1th.>ugh detection of an incr.,ased risk of thyroid cancer is unUkely, .,valuation of health probl.,ms in gen.,rai (for example, total cancer ihcidence) is a
possibility •
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Option 8t

Do not conduct a fulJ-.:aJe foUowup of the «i8ina1 study groups

There are several reasons for not conducting a second fo)Uowup of the original Utah,
Nevada, and Arizona poups. First, because of the smaU size of the exposed group, we
would not be able to detect anythu. less than an &-fold increased risk of thyroid cancer
with adeq18te (10\16) statistical probability. Thb is true even wit h the addition of 12 years
of foUowup. Since the relative rlsl! for thyroid cancer in the exposed group is estimated to
lie between ).and 6-fold, an observation of no increased risk would be of dubious value.
Second, the estimated cost of locating and sending a health questionnaire to the entire
ori81na1 study poup (N=_,831), based on the feasibility study, would be $300,000 to
S-OO,ooo. If thyroid ex.minations were performed, the estimated costs would be substantiaUy greater. Third, the scientific and public health return for an investment of this size
would be questionable, if the present study design is maintained.
Option C.

Improve the study design and enlar&e the ori8inal study IfOUPS

Improvu. the study design, and thereby the chance of obtaining meaningful results,
could be done by L'lCreasing the size of the study poups. The exposed group could be
enlarged by one of two methods. The first involves including other counties in Utah which
received substantial faUout exposure such as Iron and Kane Counties. A second method
would be to locate those persons who were born in Washington County, Utah, between 191f6
and 19», but whose families emigrated before the ()j ;ginal thyroid study began· in 196'.
This group accounts for more than one--half of the original estimated exposed group. A
feasibility study .hould first be conducted to determine whether study expansion by these
method. is possible since the results of the present feasibility study may not be applicable.
The expense of enlarging the study using these methods would be con.iderable. The
estimated costs would be $800,000 to $1,200,000 assuming the cost e.timates derived from
the present feasibilty study are applicable to the larger study and the time needed to
complete the study would be approximately three years. However, a relative risk for
thyroid cancer between 3 and " wou ld be detected with 80 percent probability if the .t....dy
was expanded in this manner.
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